Subscribe to RSS
DOI: 10.1055/s-2008-1072659
First Route to Phosphoramidites of N 2-Hydrazinoaryl- and N 2-Azoaryl-dG Adducts and Their Site-Selective Incorporation into DNA Oligonucleotides
Publication History
Publication Date:
31 March 2008 (online)
Abstract
N 2-Hydrazinoaryl and N 2-azoaryl-dG adducts of borderline carcinogens and the bladder and breast carcinogen 4-aminobiphenyl were prepared using Pd-catalyzed cross-coupling chemistry. After conversion into the phosphoramidites site-specifically damaged oligonucleotides were prepared by automated DNA synthesis. DNA Hybrids were studied with respect to their thermal stability (UV melting-temperature analysis) and circular dichroism.
Key words
DNA damage - chemical carcinogenesis - aromatic amines - N 2-adducts - cross-coupling
-
1a
Wagenknecht H.-A. Angew. Chem. Int. Ed. 2006, 45: 5583 ; Angew. Chem. 2006, 118, 5709 -
1b
Carell T.Burgdorf LT.Kundu LM.Cichon M. Curr. Opin. Chem. Biol. 2001, 5: 491 -
1c
Friedberg EC.Walker GC.Siede W. DNA Repair and Mutagenesis American Society for Microbiology Press; Washington, DC: 1995. -
1d
Schärer OD. Angew. Chem. Int. Ed. 2003, 42: 2946 ; Angew. Chem. 2003, 115, 3052 - 2
Garner RC. Mutat. Res. 1998, 402: 67 - 3
Neumann HG. Cancer Res. Clin. Oncol. 1986, 112: 100 - 4
Beland FA.Kadlubar FF. Environ. Health Perspect. 1985, 62: 19 -
5a
Famulok M.Boche G. Angew. Chem., Int. Ed. Engl. 1989, 28: 468 ; Angew. Chem. 1989, 101, 470 -
5b
Famulok M.Bosold F.Boche G. Tetrahedron Lett. 1989, 30: 321 - 6
Famulok M.Bosold F.Boche G. Angew. Chem., Int. Ed. Engl. 1989, 28: 337 ; Angew. Chem. 1989, 101, 349 - 7
Swaminathan S.Hatcher JF. Chem.-Biol. Interact. 2002, 139: 199 - 8
Swaminathan S.Hatcher JF. Environ. Mol. Mutagen. 2002, 39: 314 - 9
Kadlubar FF. Princess Takamatsu Symp. 21 1990, 329 - 10
Meier C.Boche G. Carcinogenesis 1991, 12: 1633 - 11
Meier C.Boche G. Tetrahedron Lett. 1990, 31: 1693 - 12
Elmquist CE.Stover JS.Wang Z.Rizzo CJ. J. Am. Chem. Soc. 2004, 126: 11189 - 13
Böge N.Gräsl S.Meier C. J. Org. Chem. 2006, 71: 9728 - 14
Böge N.Szombati Z.Meier C. Nucleosides, Nucleotides Nucleic Acids 2007, 26: 705 -
15a
Takamura-Enya T.Ishikawa S.Mochizuki M.Wakabayashi K. Tetrahedron Lett. 2003, 44: 5969 -
15b
Takamura-Enya T.Ishikawa S.Mochizuki M.Wakabayashi K. Chem. Res. Toxicol. 2006, 19: 770 -
16a
Gillet LCJ.Schärer OD. Org. Lett. 2002, 24: 4205 -
16b
Gillet LCJ.Alzeer J.Schärer OD. Nucleic Acids Res. 2005, 33: 1961 - 17
De Riccardis F.Bonala RR.Johnson F. J. Am. Chem. Soc. 1999, 121: 10453 - 18
Stover JS.Chowdhury G.Zang H.Guengerich FP.Rizzo CJ. Chem. Res. Toxicol. 2006, 19: 1506 - 19
Haack T.Boche G.Kliem C.Wiessler M.Albert D.Schmeiser HH. Chem. Res. Toxicol. 2004, 17: 776 - 20
Uhlmann E.Pfleiderer W. Helv. Chim. Acta 1981, 64: 1688 - 21
Zeghough D.Samsoniya S.Suvorov NN. Chem. Heterocycl. Compd. 1990, 3: 343 - 22
Amatore C.Azzabi M.Jutland AJ. J. Am. Chem. Soc. 1991, 113: 8375
References and Notes
General Procedure for the Synthesis of the N
²
-Arylhydrazino Adducts (7a,b)
Under nitrogen atmosphere 5 (1 equiv), racemic BINAP (30 mol%), Pd2dba3 (10 mol%), K3PO4 (2 equiv), triethylammonium chloride (0.1 equiv), and arylhydrazine (2 equiv) were suspended in dry DME and stirred at 80 °C. After the reaction was completed, sat. NaHCO3 and NaCl solution were added. The layers were separated and the aqueous layer was extracted three times with EtOAc. The combined organic layers were dried over Na2SO4 and the solvent was removed in vacuo. The product was isolated by column chromatography using PE-EtOAc (10% → 35%).
Compound 7a: The general procedure was conducted with 3.05 g of 5 (4.40 mmol) and 1 mL of 6a (8.8 mmol); yield 2.52 g (3.52 mmol, 80%) of 7a as a slightly brown solid. 1H NMR (400 MHz, DMSO-d
6): δ = 8.46 (s, 2 H, H-8), 7.43-6.82 (m, 9 H, HAr), 6.67 (dd, 3
J
H,H = 7.3 Hz, 3
J
H,H = 7.2 Hz, 1 H, H-1′), 5.34 (s, 2 H, NH), 4.42-4.19 (m, 2 H, H-a), 3.72-3.71 (m, 3 H, H4′, H5′a, H5′b), 3.06 (t, 3
J
H,H = 6.9 Hz, 3
J
H,H = 6.9 Hz, 2 H, Hb), 2.97-2.91 (m, 1 H, H2′a), 1.91 (s, 1 H, H2′b), 0.75 [s, 9 H, Si(CH3)3 at C3′], 0.80 [s, 9 H, Si(CH3)3 at C5′], 0.00 [s, 6 H, Si(CH3)2], -0.15 [2 × s, 2 × 3 H, Si(CH3)2] ppm. 13C NMR (101 MHz, DMSO-d
6): δ = 159.1 (C-6), 156.7 (C-2), 152.4 (C-D), 145.7 (C-A), 144.4 (C-f), 139.6 (C-8), 130.0 (C-C), 129.5 (C-c), 127.6 (C-d), 127.5 (C-e), 123.6 (C-4), 119.0 (C-B), 118.6 (CN), 114.8 (C-5), 87.1 (C-4′), 84.0 (C-1′ 71.6 (C-3′), 67.8 (C-a), 62.8 (C-5′), 39.7 (C-2′), 34.7 [2 × SiC(CH3)3], 34.3 (C-b) ppm. Mp 84-87 °C; [α]546
20 -3 (c 1.0, CHCl3). IR (KBr): 3744, 3037, 1737, 1695, 1612, 1507, 1110, 838 cm-1. HRMS-FAB: m/z calcd: 715.3698; found: 716.3736 [M + H+].
Compound 7b: The general procedure was conducted with 2.36 g of 5 (3.42 mmol) and 1.42 g of 6b (7.60 mmol); yield 1.35 g (1.71 mmol, 50%) of 7b as a yellow solid. 1H NMR (400 MHz, DMSO-d
6): δ = 8.19 (s, 1 H, H8), 7.77-7.33 (m, 13 H, Har), 6.31 (dd, 3
J
H,H = 6.7 Hz, 1 H, H1′), 5.37, 5.20
(2 × s, 2 × 1 H, NH), 4.70 (t, 3
J
H,H = 6.9 Hz, 2 H, Ha), 4.54-4.51 (m, 2 H, H3′), 3.85-3.82 (m, 1 H, H4′), 3.72-3.62 (m, 2 H, H5′a, H5′b), 3.17 (t, 3
J
H,H = 6.9 Hz, 2 H, Hb), 2.97-2.90 (m, 1 H, H2′a), 2.30-2.24 (m, 1 H, H2′b), 0.88, 0.84 [2 × s, 2 × 9 H, Si(CH3)3], 0.10, 0.00 [2 × s, 2 × 6 H, Si(CH3)2] ppm. 13C NMR (101 MHz, DMSO-d
6): δ = 159.2 (C6), 157.5, 153.1 (C4), 148.2 (C2), 144.1, 139.7 (C8), 132.0, 128.7, 126.1, 118.7 (CN), 115.1 (C5), 87.1 (C4′), 83.2 (C1′), 72.3 (C3′), 65.8 (Ca), 62.8 (C5′ 38.3 (C2′), 34.1 (Cb), 25.6, 25.5 [2 × SiC(CH3)3], -5.6, -5.1 [2 × Si(CH3)2] ppm. Mp 75-78 °C; [α]546
20 +25 (c 0.4, CHCl3). IR (KBr): 2954, 2928, 2857, 1687, 1109, 776, 740, 482 cm-1. MS (HRFAB): m/z calcd: 791.4011; found: 791.4035 [M + H]+.
Compound 10a: 1H NMR (400 MHz, benzene-d
6): δ = 7.84 [s, 1 H, H-8 (I)], 7.81 [s, 1 H, H-8 (II)], 7.71-7.41 [m, 44 H, HAr (I + II), DMTr-H (I + II)], 6.25 [dd, 3
J
H,H = 6.4 Hz, 3
J
H,H = 6.3 Hz, 2 H, H-1′ (I + II)], 4.74-4.58 [m, 2 H, NH (I)], 4.47-4.37 [m, 2 H, NH (II)], 4.16-4.05 [m, 4 H, H-a (I + II)], 3.58-3.35 (m, 12 H, OCH3, H-5′a/b (I + II), H-b(I)] 3.15-3.02 [m, 2 H, H-b (II)], 2.54-2.29 (m, 12 H, i-PrH (I + II), H-α (I + II), H-2′a/b (I + II)], 1.81 [t, 2 H, H-β (I)], 1.73 [m, 2 H, H-β (II)], 1.15-1.01 [m, 24 H, CH3
i-Pr (I + II)] ppm. 13C NMR (101 MHz, benzene-d
6): δ = 160.1, 159.3, 158.7, 148.2, 145.8, 143.3, 138.0, 137.4, 136.1, 132.0, 131.4, 130.6, 130.1, 129.8, 119.0, 113.7, 113.0, 111.0, 87.1, 74.4, 74.2, 66.0, 54.8, 45.3, 43.6, 35,1, 24.7, 24.6, 22.8 ppm. 31P NMR (162 MHz, benzene-d
6): δ = 149.35, 149.19 ppm. Mp 68-71 °C. [α]546
20 +183 (c 1.0, CHCl3). IR KBr): 3870, 3816, 3752, 3744, 3676, 3447, 2966, 1654, 1609, 1581, 1508, 1465, 1383, 1250, 1179, 1034, 829 cm-1. MS-FAB: m/z calcd: 989.4353; found: 990.5 [M + H]+.
Compound 11a: 1H NMR (400 MHz, benzene-d
6): δ = 7.88 [s, 1 H, H-8 (I)], 7.85 [s, 1 H, H-8 (II)], 7.62-6.58 [m, 49 H, DMTr-H (I + II), HAr (I + II)], 6.27-6.18 [m, 2 H, H-1′ (I + II)], 5.07-4.95 [m, 2 H, H-3′ (I + II)], 4.73-4.67 [m, 4 H, H-a (I + II)], 4.13-4.06 [m, 2 H, H-4′ (I + II)], 3.54-3.26 [m, 20 H, OCH3 (I + II), H-b (I + II), H-5′ (I + II)], 3.00-2.82 [m, 2 H, H-2′a (I + II)], 2.72-2.61 [m, 8 H, i-PrH (I + II), H-a (I + II)], 2.56-2.47 [m, 1 H, H-2′b (I)], 2.41-2.29 [m, 1 H, H-2′b (II)], 1.73-1.67 (m, 4 H, H-b (I + II)], 1.13-1.05 [m, 24 H, CH3
i-Pr (I + II)] ppm. 13C NMR (101 MHz, benzene-d
6):
δ = 190.6, 186.5, 185.4, 177.7, 169.4, 168.0, 163.6, 159.3, 153.4, 146.1, 145.8, 143.3, 136.3, 132.1, 130.7, 129.9, 129.4, 124.0, 113.8, 87.6, 87.0, 54.8, 47.5, 43.6, 35.2, 24.6 ppm. 31P NMR (162 MHz, benzene-d
6): δ = 149.46, 149.16 ppm. Mp 86-89 °C; [a]546
20 +39 (c 1.0, CHCl3). IR (KBr): 3854, 3744, 3676, 3432, 2965, 2227, 1607, 1508, 1445, 1341, 1251, 1178, 1034 cm-1. MS-FAB: m/z calcd: 987.4197; found: 988.7 [M + H]+.
Compound 10b: 1H NMR (400 MHz, benzene-d
6): δ = 7.88 [s, 1 H, H8 (I)], 7.86 [s, 1 H, H8 (II)], 7.62-6.58 [m, 52 H, DMTr-H (I + II), Har (I + II)], 6.29-6.19 [m, 2 H, H1′ (I + II)], 5.76, 5.37 [2 × s, 2 × 2 H, NH (I + II)], 5.04-5.01 [m, 2 H, H3′ (I + II)], 4.60-4.50 [m, 4 H, Ha (I + II)], 4.13-4.08 [m, 2 H, H4′ (I + II)], 3.52-3.17 [m, 20 H, OCH3 (I + II), Hb (I + II), H5′ (I + II)], 2.98-2.93 [m, 1 H, H2′a (I)], 2.89-2.84 [m, 1 H, H2′a (II)], 2.71-2.68 [m, 8 H, i-PrH (I + II) + a′ (I + II)], 2.56-2.48 [m, 1 H, H2′b (I)], 2.41-2.34 (m, 1 H, H2′b (II)], 1.73-1.67 [m, 4 H, b′ (I + II)], 1.13-1.05 [m, 24 H, CH3
i-Pr (I + II)] ppm. 13C NMR (101 MHz, benzene-d
6):
δ = 159.1, 155.6, 153.2, 144.1, 139.7, 135.6, 134.6, 130.0, 127.8, 122.3, 118.8, 116.2, 109.1, 87.6, 83.1, 70.8, 65.8, 61.7, 39.7, 34.4 ppm. 31P NMR (162 MHz, benzene-d
6): δ = 149.87, 149.09 ppm. Mp 75-78 °C; [a]546
20 +33 (c 0.1, CHCl3). IR (KBr): 3744, 3675, 2966, 1607, 1457, 1200, 1077, 978 cm-1. MS-FAB: m/z calcd 1065.4666; found: 1066.6 [M + H]+.
Compound 11b: 1H NMR (400 MHz, benzene-d
6): δ = 7.88 [s, 1 H, H8 (I)], 7.86 [s, 1 H, H8 (II)], 7.62-6.58 [m, 59 H, DMTr-H (I + II), Har (I + II)], 6.29-6.19 [m, 2 H, H1′ (I + II)], 5.04-5.01 (m, 2 H, H3′ (I + II)), 4.60-4.50 [m, 4 H, Ha (I + II)], 4.13-4.08 [m, 2 H, H4′ (I + II)], 3.52-3.17 [m, 20 H, OCH3 (I + II), Hb (I + II), H5′ (I + II)], 2.98-2.93 [m, 1 H, H2′a (I)], 2.89-2.84 [m, 1 H, H2′a (II)], 2.71-2.68 [m, 8 H, i-PrH (I + II) + α′ (I + II)], 2.56-2.48 [m, 1 H, H2′b(I)], 2.41-2.34 [m, 1 H, H2′b(II)], 1.73-1.67 [m, 4 H, β′ (I + II)], 1.13-1.05 [m, 24 H, CH3
i-Pr (I + II)] ppm. 13C NMR (101 MHz, benzene-d
6): 159.1, 155.6, 153.2, 144.1, 139.7, 135.6, 134.6, 130.0, 127.8, 122.3, 118.8, 116.2, 109.1, 87.6, 83.1, 70.8, 65.8, 61.7, 39.7, 34.4 ppm. 31P NMR (162 MHz, benzol-d
6): δ = 149.29, 149.08 ppm. Mp 63-65 °C; [α]546
20
-13 (c 0.4, CHCl3). IR (KBr): 3821, 3675, 3447, 2966, 1734, 1700, 1653, 1507, 1363, 1179, 1033, 829 cm-1. MS-FAB: m/z calcd: 1063.4510; found: 1064.7 [M + H]+.